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Background: The parasites Trypanosoma rangeli and Trypanosoma cruzi share vectors and hosts over a wide
geographical area in Latin America. In this study, we propose a single molecular approach for simultaneous
detection and typing of T. rangeli and T. cruzi.
Methods: A restriction fragment length polymorphism analysis of the mitochondrial cytochrome oxidase II gene
(COII-RFLP) using enzyme AluI and different amounts of DNA from the major genetic groups of T. rangeli and
T. cruzi (KP1+/KP1- and DTU-I/DTU-II) was carried out. The same marker was tested on the other T. cruzi DTUs
(DTU-III to DTU-VI) and on DNA extracted from gut contents of experimentally infected triatomines.
Results: The COII PCR generates a ~400 bp fragment, which after digestion with AluI (COII-RFLP) can be used to
distinguish T. rangeli from T. cruzi and simultaneously differentiate the major genetic groups of T. rangeli (KP1+ and KP1-)
and T. cruzi (DTU-I and DTU-II). The COII-RFLP generated bands of ~120 bp and ~280 bp for KP1+, whereas for KP1- no
amplicon cleavage was observed. For T. cruzi, digestion of COII revealed a ~300 bp band for DTU-I and a ~250 bp band
for DTU-II. For DTU-III to DTU-VI, COII-RFLP generated bands ranging from ~310 to ~330 bp, but the differentiation
of these DTUs was not as clear as the separation between DTU-I and DTU-II. After AluI digestion, a species-specific
fragment of ~80 bp was observed for all DTUs of T. cruzi. No cross-amplification was observed for Leishmania spp.,
T. vivax or T. evansi.
Conclusions: The COII-RFLP allowed simultaneous detection and typing of T. rangeli and T. cruzi strains according
to their major genetic groups (KP1+/KP1- and DTU-I/DTU-II) in vitro and in vivo, providing a reliable and sensitive
tool for epidemiological studies in areas where T. rangeli and T. cruzi coexist.
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Trypanosoma rangeli and Trypanosoma cruzi are proto-
zoan parasites that infect sylvatic and domestic mammals
and humans in several Central and South American coun-
tries [1,2]. T. rangeli is considered nonpathogenic to mam-
mals, while T. cruzi, the causative agent of Chagas disease,
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stated.leading to morbidity or mortality [3-5]. Since these para-
sites share a variety of soluble antigens, vectors, and hosts
over a wide geographical area, mixed infections in triato-
mines and mammals may occur [6,7], reinforcing the need
for specific diagnosis [3,4,8-13].
Several nuclear and mitochondrial molecular markers
have been used for detection and differentiation of
T. rangeli and T. cruzi [9,14-19], but none of them
allows typing of strains according to the currently de-
scribed genotypes. The sequence variability of the kin-
etoplast DNA (kDNA) minicircle was used to classify
T. rangeli strains into two major genetic groups, termedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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others [4,23].
Assessment of T. rangeli genetic variability is based on
studies of one or a few nuclear or mitochondrial markers
[2,23-26], which indicate the intraspecific genetic vari-
ability of this parasite and confirm the KP1+ and KP1-
genetic groups [21,22].
Differently from T. rangeli, the genomic plasticity of
T. cruzi is well described in the literature [6,8,27-37].
Strains of this parasite have been classified in six discrete
typing units or DTUs (DTU-I to DTU-VI), which were fur-
ther divided into subtypes by several authors [29,38,39],
and a recent genotype identified as TcBat [35,36,40].
Restriction fragment length polymorphism (RFLP) ana-
lysis of the mitochondrial cytochrome oxidase II (COII)
subunit 2 gene, termed COII-RFLP, was originally pro-
posed by Freitas et al. [30] and modified by Abolis et al.
[7] to distinguish T. cruzi DTUs isolated from southern
Brazil. This method has not yet been used to detect and
type T. rangeli strains. In this study, considering the sym-
patric occurrence in mammals and vectors and the genetic
plasticity of T. rangeli and T. cruzi, we used COII-RFLP as
a single molecular approach for simultaneous detection
and typing of these two parasites.
Methods
Parasites
Parasite strains used in this study are shown in Table 1.
T. rangeli KP1+ and KP1- strains were characterized
according to the methodology of Vallejo et al. [21].
T. cruzi DTUs were the standard strains described by
Zingales et al. [35,36].
Genomic DNA extraction and quantification
T. rangeli DNA was extracted by the standard phenol-
chloroform method, and T. cruzi DNA was extracted as
previously described [41]. DNA from Leishmania ama-
zonensis, Leishmania braziliensis, Leishmania infantum,
Trypanosoma evansi and Trypanosoma vivax was ex-
tracted by the standard phenol-chloroform method and
used as controls. Extracted DNA was eluted in TE buffer
(10 mM Tris–HCl pH 8.0 and 1 mM EDTA pH 8.0),
quantified by spectrophotometry at 260/280 nm, and
stored at −20°C until use.
COII-RFLP analysis
Amplification of the COII gene by PCR following re-
striction fragment length polymorphism analysis with
AluI (COII-RFLP) was used to simultaneously detect
and differentiate strains of T. rangeli (KP1+/KP1-) and
T. cruzi (DTU-I to DTU-VI).
COII amplification was carried out as described by
Freitas et al. [30] with modifications proposed by
Abolis et al. [7]. Briefly, each amplification reaction wasperformed in a final volume of 15 μL, containing 3.1 pmol
of primers Tcmit-10 (5′-CCA TAT ATT GTT GCA TTA
TT-3′) and Tcmit-21 (5′-TTG TAA TAG GAG TCA TGT
TT-3′), 2 ng of DNA (ideal amount for amplification
in relation to the tested amounts, from 0.1 fg to
2 ng), 2.5 μM of dNTP, 3.5 mM of MgCl2, and 1 U
of Platinum Taq DNA polymerase (Invitrogen) in the
buffer provided by the manufacturer. Amplification
was processed in a Techne TC-512 thermocycler with
initial denaturation at 94°C for 1 min, followed by
30 cycles (94°C for 30 s, 48°C for 2 min, and 72°C
for 2 min) and a final extension step at 72°C for 10 min.
Ten microliters of unpurified amplification product was
digested with 10 U (1 μL) of the AluI restriction enzyme
(New England BioLabs) in the buffer (1 μL) provided by
the manufacturer for 16 h at 37ºC. From artificial
mixtures of DNA of the four major genetic groups
processed simultaneously in a single reaction, the groups
DTU-I, DTU-II and KP1+ were considered an internal
control of enzymatic digestion. The resulting fragments
were analyzed in 6% polyacrylamide gel, silver-stained
and digitally recorded.
T. rangeli COII gene sequencing and comparative
sequence analysis
The T. rangeli COII gene fragment (~400 bp) amplified
by PCR from T. rangeli Choachí and SC-58 strains was
cloned in the pGEM®-T Easy Vector System plasmid
(Promega) and transformed in Escherichia coli DH5α
competent bacteria by heat shock according to standard
protocols. After culture for 16–18 h at 37°C on Luria-
Bertani medium (LB), three positive clones were sub-
jected to recombinant DNA extraction by the CTAB
(cetyltrimethylammonium bromide) method [42] and
checked by PCR for the presence of the insert. The
plasmid inserts of the three clones had both strands
sequenced using the DYEnamic™ ET Terminator Kit,
using M13 primers in a MegaBACE 1000 sequencer
(GE Healthcare). The sequences obtained were as-
sembled and analyzed using the Phred/Phrap/Consed
package [43] following comparison of all high-quality
sequences (Phred > 20) with public databases using
the BLAST routine. Sequences of the COII gene from
T. cruzi Sylvio [GenBank: EU302222.1], Esmeraldo
[GenBank: AF359035.1], 231 [GenBank: DQ343720.1],
CAN III [GenBank: AF359030.1], SO3 cl5 [GenBank:
AF359039.1] and CL Brener [GenBank: AF359041.1]
strains were retrieved from GenBank. Multiple align-
ments of nucleotide sequences were performed using
ClustalW software [44], and alignment was trimmed
by using the BioEdit software [45]. COII sequences from
T. rangeli Choachí and SC-58 strains were deposited in
GenBank under accession numbers HQ691249.1 and
HQ691248.1, respectively.
Table 1 Trypanosomatid species and strains used in this study, their original hosts, geographical origins and genetic
groups
Species Strain Hosts Geographical origin* Genetic group**
Trypanosoma cruzi Sylvio X10 Homo sapiens Brazil (PA) DTU-I
Esmeraldo cl3 H. sapiens Brazil (BA) DTU-II
231 H. sapiens Brazil (MG) DTU-III
CAN III H. sapiens Brazil (PA) DTU-IV
SO3 cl5 Triatoma infestans Bolivia DTU-V
CL Brener T. infestans Brazil (RS) DTU-VI
150 H. sapiens Brazil (MG) DTU-I
328 H. sapiens Brazil (PR) DTU-II
SC-90 Didelphis aurita Brazil (SC) DTU-I
SC-95 H. sapiens Brazil (SC) DTU-II
Trypanosoma rangeli Choachí Rhodnius prolixus Colombia KP1+
H8GS H. sapiens Colombia KP1+
San Agostín H. sapiens Colombia KP1+
D3493 R. prolixus Colombia KP1+
H14 H. sapiens Honduras KP1+
H9 H. sapiens Honduras KP1+
Macias H. sapiens Venezuela KP1+
Palma 2 R. prolixus Venezuela KP1+
R1625 H. sapiens El Salvador KP1+
B450 Rhodnius robustus Brazil (PA) KP1+
1545 R. prolixus Colombia KP1+
SC-58 Echimys dasythrix Brazil (SC) KP1-
SC-61 E. dasythrix Brazil (SC) KP1-
SC-68 Panstrongylus megistus Brazil (SC) KP1-
SC-74 P.megistus Brazil (SC) KP1-
SC-75 P.megistus Brazil (SC) KP1-
C-23 Aotus trivirgatus Colombia KP1-
Trypanosoma evansi Te Canis familiaris Brazil (RS) NA
Trypanosoma vivax Tv Bos taurus Brazil (PB) NA
Leishmania amazonensis M2269 H. sapiens Brazil (PA) NA
Leishmania braziliensis M2903 H. sapiens Brazil (PR) NA
Leishmania infantum LRM75 H. sapiens Brazil (PI) NA
* Letters in parentheses indicate the Brazilian state where the strain was isolated (BA, Bahia; MG, Minas Gerais; PA, Pará; RS, Rio Grande do Sul; SC, Santa Catarina).
** DTU-I to DTU-VI are the different T. cruzi DTUs (Discrete Typing Units) described by Zingales et al. [35,36], and KP1+/KP1- are the T. rangeli genetic groups
described by Vallejo et al. [21]. NA –Not Applicable.
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of T. rangeli and T. cruzi by PCR
The COII-RFLP for detecting and typing T. rangeli
(KP1+/KP1) and T. cruzi (DTU-I/DTU-II) was tested
in vitro with DNA of each genetic group and in artificial
mixtures of DNA in the ratios 1:1 to 1:9 (corresponding
to amounts from 2 ng to 0.02 ng) and in vivo in triato-
mines, simulating natural infections. Groups of ten fifth-
instar Rhodnius prolixus were experimentally infected
using an artificial feeding apparatus, using pure or mixedculture-derived epimastigotes from the T. cruzi SC-90
(DTU-I) and SC-95 (DTU-II), T. rangeli Choachí (KP1+)
and SC-58 (KP1-) strains, in the following combinations:
DTU-I or DTU-II alone, KP1(+) and KP1(−) alone,
DTU-I + KP1(+), DTU-I + KP1(−), DTU-II + KP1(+), DTU-
II + KP1(−), DTU-I +DTU-II + KP1(+), DTU-I +DTU-II +
KP1(−), DTU-I + KP1(+) + KP1(−), DTU-II + KP1(+) +
KP1(−), and DTU-I + DTU-II + KP1(+) + KP1(−). After
30 to 45 days of the infective meal, the midgut and
hindgut of five insects were removed and total DNA
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the other T. cruzi DTUs (DTU-III to VI), the performance
of the COII-RFLP assay was not tested with artificial or
natural mixed infections.
As an external control to compare the efficiency of
COII-RFLP in separating T. cruzi DTU-I from DTU-II
and T. rangeli KP1+ from KP1-, the ribosomal RNA
(rRNA) gene from the same samples was amplified,
using a multiplex PCR reaction as described by Souto
et al. [17].
Results
Amplification of the COII gene from all T. cruzi strains
representing the six DTUs and from all T. rangeli strains
representing the two major genetic groups (KP1+
and KP1-) revealed the expected band of ~400 bp
(Figure 1A). Digestion of the amplified fragments with
AluI generated the RFLP profile shown in Figure 1B.
Regardless of DTU, an 80 bp band was observed for all T.
cruzi strains; this band was absent in T. rangeli. Except
for T. cruzi DTU-III, DTU-V and DTU-VI, digestion
products ranging from 250 to 330 bp allowed the
DTU-I, DTU-II and DTU-IV strains to be distinguished
(Figure 1B). Digestion of COII amplicon from T. rangeli
KP1+ strains generated restriction fragments of ap-
proximately 125 and 280 bp, while the amplicons fromFigure 1 COII gene assayed from Trypanosoma cruzi, Trypanosoma rang
products from T. cruzi (lines 1 to 6), T. rangeli (lines 7 to 23); B) RFLP pattern ob
from T. cruzi (DTU-I to DTU-VI) strains and T. rangeli (KP1+ and KP1-) resolved i
Ladder (Invitrogen), NC = Negative control (No DNA added).all KP1- strains still consisted of ~400 bp, indicating
that they were not digested by AluI (Figure 1B). No ampli-
fication of the COII gene was observed for T. evansi,
T. vivax, L. amazonensis, L. braziliensis and L. infantum
(Figure 1A, 1B).
The absence of cleavage of the COII gene for T. rangeli
KP1- strains was further investigated by sequencing
and comparative analysis of the amplification products.
Multiple sequence analysis was carried out using the
COII gene from T. rangeli Choachí (377 bp) and SC-58
(375 bp) strains, and T. cruzi COII gene sequences
retrieved from GenBank. Sequences of the T. rangeli
COII gene from Choachí (KP1+) and SC-58 (KP1-)
strains were 95.2% similar to each other, showing 15
nucleotide substitutions, an insertion (CTT) on positions
48–50 for the Choachí strain, and the absence of the AluI
cleavage site in the SC-58 strain (positions 113–116), which
was present in the Choachí strain (Figure 2). The inter-
specific analysis of COII gene sequences showed similar-
ities between T. rangeli and T. cruzi. The number of single
nucleotide polymorphisms (SNPs) between T. cruzi DTU-I
and DTU-II strains (90.6% similarity) was twice that
observed between T. rangeli KP1+ and KP1- strains.
T. rangeli KP1+ exhibited a similarity of 85.9% with DTU-I
and 85.1% with DTU-II, whereas KP1- showed 85.0% simi-
larity with DTU-I and 84.2% with DTU-II.eli and other trypanosomatids (Table 1). A) COII gene amplification
tained by AluI digestion of the cytochrome oxidase subunit II (COII) gene
n 6% polyacrylamide gel stained with silver nitrate. MW= 100 bp DNA
Figure 2 Alignment of Trypanosoma rangeli and Trypanosoma cruzi COII gene. Dots indicate identity; dashes indicate gaps introduced to
maximize the alignment of the sequences; bold nucleotides on dark-gray background indicate the AluI restriction sites, and light-gray boxes indicate
the annealing sites of primers Tcmit-10 (positions 1–20) and Tcmit-21 (positions 359–378).
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T. rangeli and T. cruzi strains in artificial DNA mixtures;
as little as 0.02 ng of DNA from both parasites could
be detected (Figure 3). For this purpose, detection and
typing of parasites present in the intestinal tracts of ex-
perimentally infected triatomines were also performed
by COII-RFLP, with interesting results. As shown in
Figure 4, a clear differentiation between T. rangeli and
T. cruzi was achieved, as well as typing of these par-
asites according to their major genetic groups. The
T. cruzi diagnostic band (~80 bp) observed in the
COII-RFLP using extracted DNA from each parasite
and genetic group was also present in the assay per-
formed with the gut contents from experimentally in-
fected triatomines, revealing the usefulness of the
method. Even when T. rangeli (KP1+ and KP1-) and
T. cruzi (DTU-I and DTU-II) are present in the same
triatomine, which is commonly observed in nature, it
is possible to identify each individual parasite species
and genetic group.
The multiplex rRNA PCR was also able to detect and
distinguish T. cruzi DTU-I (260 bp) and DTU-II (300 bp)
strains in both reconstitution tests (artificial DNA mix-
ture) and in the experimentally infected triatomines. For
the T. rangeli strains, a single band of ~210 bp was ob-
served for both KP1+ and KP1- genotypes (data notshown), in contrast to COII-RFLP, which distinguished
these two genetic groups.
Discussion and conclusions
The COII-RFLP described in this study allows specific
detection of T. rangeli and T. cruzi, even in mixed infec-
tions, as well as assessment of their major genetic
groups circulating in Latin America, i.e., KP1+/KP1- for
T. rangeli and DTU-I/DTU-II for T. cruzi [46,47]. This
assay was also tested using DNA from kinetoplastids
of different species (L. braziliensis, L. amazonensis,
L. infantum, T. vivax and T. evansi), with negative results
on PCR, confirming that the COII primers are specific
for T. cruzi and T. rangeli. Other Leishmania species
of medical and epidemiological importance such as
those belonging to the L. guyanensis complex, as well as
L. naiffi and L. lainsoni remain to be evaluated. However,
considering the different organization of the Leishmania
sp. maxicircles compared to Trypanosoma spp. and the
results obtained for L. braziliensis, L. amazonensis and
L. infantum, we should expect no cross-amplification.
The COII-RFLP, similar to the multiplex PCR targeting
rRNA proposed by Souto et al. [17], is able to differentiate
T. cruzi DTU-I, DTU-II and T. rangeli, with the additional
advantage of distinguishing the parasite’s KP1+ and KP1-
genotypes. However, in artificial mixtures where DNA
Figure 4 Profiles of COII-RFLP from Trypanosoma cruzi and Trypanosoma rangeli in triatomine intestinal tracts. Silver-stained 6% polyacrylamide
gel reveals the electrophoretic profiles of the COII-RFLP assay for detection and typing of T. rangeli (KP1+ and KP1- strains) and T. cruzi (DTU-I and
DTU-II strains) in the intestinal tract of Rhodnius prolixus experimentally infected with single or mixed strains and genetic groups. MW= 100 bp
DNA Ladder (Invitrogen, USA). NC = Negative control (No DNA added).
Figure 3 Profiles of COII-RFLP from DNA of each genetic group of Trypanosoma cruzi and Trypanosoma rangeli and from artificial
mixtures with different ratios of DNA. Lines 1 to 4 are patterns of PCR-RFLP with AluI in 6% polyacrylamide gel stained with silver from DNA of
T. cruzi (DTU-I and DTU-II) and T. rangeli (KP1+ and KP1-), and lines 7 to 21 are artificial mixtures in the ratios 1:1 to 1:9, with amounts of DNA ranging
from 2 ng to 0.02 ng. NC = negative control. MW= 100 bp DNA Ladder.
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from KP1+ showed a lower intensity, indicating that the
amount of DNA in the sample, incomplete enzymatic di-
gestion, or competition by enzymes of genetic groups that
had larger amounts of DNA may influence the results.
The absence of cleavage by AluI for the T. rangeli KP1-
COII gene was due to a single nucleotide polymorphism
(SNP) on the enzyme recognition site, as revealed by high-
quality sequencing of the amplicons. This result was con-
firmed by COII-RFLP performed with artificial mixtures
of DNA of the four major genetic groups (DTU-I, DTU-II,
KP1+ and KP1-) in a single reaction, where KP1- was the
only strain that was not cut by the enzyme. This difference
allows a clear distinction of T. rangeli KP1+ from KP1-
strains in the COII-RFLP analysis. This is also the first
analysis of a maxicircle gene from T. rangeli kDNA, indi-
cating that both maxi- and minicircles can be used for
detection and genotyping strains of this taxon.
Due to the overlapping geographical distribution and
the sharing of host and vector species as well as antigens
by T. rangeli and T. cruzi, the existence of mixed infec-
tions in mammals and triatomines is a serious problem
for diagnosis and epidemiological studies of the two par-
asites [2,4,11-13]. The COII-RFLP assay described here
proved to be able to detect DNA and to assess the genetic
groups of both parasites in artificial mixtures in vitro and
in vivo in a single assay on polyacrylamide gel, because the
resolution of the agarose gel to discriminate RFLP profiles
was so low.
Several studies have successfully developed molecular
markers to detect mixed infections, but all of them lack
the ability to differentiate the genetic groups of these
parasites in a simple and straightforward way, requiring
the use of further molecular methods [9,19,48]. The in-
consistency of results obtained using different markers,
along with the genetic plasticity of both T. cruzi and
T. rangeli, have led several authors to use different
methods to achieve proper detection and typing of para-
sites in natural mixed infections in triatomine bugs [8].
Other investigators have corroborated our findings by
showing that COII-RFLP detects mixed infections con-
taining the two major DTU strains of T. cruzi (DTU-I
and DTU-II) [46,47] isolated from naturally infected tria-
tomines, demonstrating the epidemiological application
of this molecular marker [7], but not including the typing
of the strains according to their genotypes. Hamilton
et al. [49] described a fluorescence-based method for typ-
ing T. rangeli strains; however, this method is laborious,
requires the use of DNA sequencers, and considers the
existence of five different genetic groups for T. rangeli
(A-E) [50-52] that are comprised within the KP1+ and
KP1- lineages. In summary, T. rangeli KP1+ strains from
Vallejo et al. [21] include strains isolated from Central
America, Colombia, Venezuela and Brazil in Group A,whereas KP1- includes Groups B (Brazil), C (Central
America, Colombia, Peru), D (southern Brazil) and E
(central Brazil) [49-52].
Considering the wide genetic variability, including intra-
DTU variation, and the extensive geographic ranges of the
parasites studied here, the COII-RFLP was assayed with a
limited but representative number of samples. The results
showed that compared to the multiplex PCR targeting the
rRNA gene, COII-RFLP has a clear advantage in differen-
tiating T. rangeli KP1+ and KP1- groups and simultan-
eously T. cruzi DTU-I and DTU-II, the most prevalent
genotypes circulating in Central and South America. Thus,
COII-RFLP proved to be a simple and useful tool for mo-
lecular epidemiology studies in areas where T. rangeli and
T. cruzi are sympatric.
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